0
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¾Ï ȯÀÚÀÇ Ç×¾ÏÁ¦ ÀÓ»ó½ÃÇè¿¡ ´ëÇÑ Àνİú ¸¸Á·µµ

Perception and Satisfaction of Anticancer Drug Clinical Trials in Cancer Patients

Á¾¾ç°£È£¿¬±¸ 2019³â 19±Ç 1È£ p.18 ~ 26
KMID : 1035120190190010018
ÀüÁÖ°æ ( Jeon Ju-Kyung ) - ¼­¿ï¾Æ»êº´¿ø °£È£ºÎ

±èÁ¤Çý ( Kim Jeong-Hye ) - ¿ï»ê´ëÇб³ ÀÓ»óÀü¹®°£È£ÇÐ

Abstract

Purpose: The purpose of this study was to investigate the perception and satisfaction of cancer patients participating in clinical trials of anticancer drugs and the factors affecting their satisfaction.

Methods: The participants were cancer patients who participated in more than two cycles of clinical trials at a tertiary hospital in Seoul, Korea. Questionnaires were used to assess the perception and satisfaction of clinical trials of anticancer drugs.

Results: A total of 106 patients participated. The average perception and satisfaction regarding clinical trials among patients on a 5 point scale was 3.99¡¾0.45 and 4.09¡¾0.55 respectively. There was a significant difference in the correlation among participants' perception and their satisfaction (r =.67, p<.001). Regression analysis revealed that satisfaction was explained by, perception of clinical trials (¥â =.67, p<.001), participation period 30~59 days (¥â =.21, p=.009), and participation period over 60 days (¥â=.20, p=.013). These variables explained 48.7% of the variance of clinical trial satisfaction.

Conclusion: The results of this study suggest that changes in perceptions of clinical trials are needed to improve satisfaction of anticancer drug clinical trials. This can be used as a basis for improving the quality of clinical trials and education programs for cancer patients participating in clinical trials.
KeyWords
¾Ï, ÀÓ»ó½ÃÇè, ÀνÄ, ¸¸Á·µµ
Neoplasms, Clinical trial, Perception, Personal satisfaction
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
 
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed